Communiqués Shuttle Pharmaceuticals Holdings, Inc.

Actions

SHPH

US8256935003

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 25/09/2026			Varia. 5j.	Varia. 1 janv.
4,010 ^USD	+0,25%		+24,92%	-77,72%

24/09	Shuttle Pharmaceuticals Holdings, Inc. publie ses résultats pour le deuxième trimestre et les six mois clos le 30 juin 2026	CI
14/07	Les plus fortes hausses de la mi-séance	MT

Communiqués

24/09	Shuttle Pharmaceuticals : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)	PU
28/08	Shuttle Pharmaceuticals Holdings, Inc. Announces Receipt of NASDAQ Noncompliance Letter	NE
26/06	United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site	NE
25/06	United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting	NE
09/06	Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time	NE
14/05	Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs	NE
07/05	E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner	AQ
01/05	United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation	NE
30/04	Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner	NE
30/03	RETRANSMISSION, Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows	AQ
27/03	Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows	NE
26/03	Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows	NE
12/03	E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals’ $3.5 Million Public Offering	AQ
06/03	Shuttle Pharmaceuticals Announces $3.5 Million Public Offering	NE
14/01	Shuttle Pharmaceuticals - Utah Approves AI Prescriptions Drugs, How AI Is Saving Time, Cutting Costs and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever	AQ
13/01	Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever	NE
21/11	Shuttle Pharmaceuticals Acquires AI Health Platform	NE
03/11	Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00	NE
03/11	Shuttle Pharmaceuticals (NASDAQ: SHPH) Harnesses AI to Transform Cancer Drug Discovery	AQ
21/10/25	Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform	NE
13/10/25	Shuttle Executes LOI with Molecule.ai	AQ
10/10/25	Shuttle Executes LOI with Molecule.ai	AQ
09/10/25	Shuttle to Enter $3.24 Billion AI Pharmaceutical Market	AQ
14/08/25	Shuttle Pharma Provides Second Quarter 2025 Corporate Update	AQ
24/06/25	Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market	AQ